Low Blood Count Can Lead To Cardiac Arrest, Says Pharma Firm

The heart needs the blood to pump, the chief operating officer, Sterling Biopharma Limited, Mr. Adebayo Adepoju said, even as he warned that there could be cardiac arrest in the process when the needed blood is not available.

Adepoju who disclosed this, while speaking to LEADERSHIP at the official launch of Fejeron Blood Tonic in Lagos, said blood is like putting oil in the engine of a vehicle. “If it is lower than it should be, it could lead to weakness. Low blood count is one of the reasons why people are collapsing on the road or in the car,” he explained.

He identified some natural ways of boosting blood in the body such as the consumption of fruits and vegetables, but quickly warned that many of them are grown with different chemicals, making people to lose the natural benefits. “Meanwhile, there are cheaper and safer ways of getting the same blood, that is why Fejeron, a blood tonic was launched,” he added.

RELATED

At BRICS Summit,Tinubu Demands Reform Of Global Financial, Health Systems

3 minutes ago

Mixed Sentiment To Dominate Stocks Performance Amid Cautious Optimism This Week

27 minutes ago

The COO said the nature of stress and fatigue that Nigerians encounter on a daily basis requires that their physical and mental wellbeing is well supported to function at its best and that was why Fejeron Blood Tonic is uniquely formulated for everyone regardless of age or gender.

Adepoju disclosed that Fejeron Blood Tonic contains iron, Vitamin B12 and folic acid, all essential components that help to facilitate adequate blood supply and replenishment to the body with vital vitamins, while enabling a strong immune system.

Since its market introduction, the Fejeron has quickly become one of the well sought-after new brands in the pharmaceutical category and the Product Manager, Olumide Ogunremi, linked the warm embrace of the product to its quality and appeal to the needs of the Nigerian.

Ogunremi said, “The quick acceptance of Fejeron Blood Tonic in Nigeria is not a surprise to us. The enthusiasm to try out the product and the return purchases across the biggest pharmaceutical markets in Nigeria validate the quality of the product and timeliness of its emergence.”